HomeCompareFMBIO vs KMB

FMBIO vs KMB: Dividend Comparison 2026

FMBIO yields 10.98% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FMBIO wins by $21.72M in total portfolio value
10 years
FMBIO
FMBIO
● Live price
10.98%
Share price
$26.45
Annual div
$2.91
5Y div CAGR
53%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.76M
Annual income
$17,342,271.90
Full FMBIO calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — FMBIO vs KMB

📍 FMBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFMBIOKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FMBIO + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FMBIO pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FMBIO
Annual income on $10K today (after 15% tax)
$933.55/yr
After 10yr DRIP, annual income (after tax)
$14,740,931.11/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, FMBIO beats the other by $14,736,492.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FMBIO + KMB for your $10,000?

FMBIO: 50%KMB: 50%
100% KMB50/50100% FMBIO
Portfolio after 10yr
$10.90M
Annual income
$8,673,747.12/yr
Blended yield
79.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

FMBIO
No analyst data
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FMBIO buys
0
KMB buys
0
No recent congressional trades found for FMBIO or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFMBIOKMB
Forward yield10.98%5.25%
Annual dividend / share$2.91$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR53%17%
Portfolio after 10y$21.76M$45.9K
Annual income after 10y$17,342,271.90$5,222.34
Total dividends collected$21.35M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: FMBIO vs KMB ($10,000, DRIP)

YearFMBIO PortfolioFMBIO Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$12,380$1,680.40$11,314$614.45+$1.1KFMBIO
2$16,222$2,974.77$12,867$760.19+$3.4KFMBIO
3$22,931$5,573.48$14,713$945.27+$8.2KFMBIO
4$35,802$11,265.59$16,924$1,181.90+$18.9KFMBIO
5$63,458$25,150.37$19,596$1,486.64+$43.9KFMBIO
6$131,644$63,743.63$22,850$1,882.16+$108.8KFMBIO
7$329,944$189,085.38$26,849$2,399.80+$303.1KFMBIO
8$1,030,691$677,650.73$31,812$3,083.36+$998.9KFMBIO
9$4,129,764$3,026,924.53$38,033$3,994.72+$4.09MFMBIO
10$21,761,119$17,342,271.90$45,918$5,222.34+$21.72MFMBIO

FMBIO vs KMB: Complete Analysis 2026

FMBIOStock

First Midwest Bancorp, Inc. operates as the bank holding company for First Midwest Bank that provides various banking products and services. The company accepts checking, NOW, money market, and savings accounts, as well as various types of short-term and long-term certificates of deposit. Its loan products include working capital needs; accounts receivable financing; inventory and equipment financing; sector-based lending, including healthcare, asset-based lending, structured finance, and syndications; agricultural loans; and mortgages, home equity lines and loans, personal loans, specialty loans, and consumer secured and unsecured loans, as well as funding for the construction, purchase, refinance, or improvement of commercial real estate properties. In addition, the company offers treasury management products and services comprising automated clearing house collection, lockbox, remote deposit capture, and financial electronic data interchange; wire transfer, account reconciliation, controlled disbursement, direct deposit, and positive pay services; information reporting services; corporate credit cards; and liquidity management, fraud prevention, and merchant services. Further, it provides fiduciary and executor, financial planning, investment advisory, employee benefit plan, and private banking services to corporate and public retirement plans, foundations and endowments, high net worth individuals, and multi-employer trust funds. Additionally, the company offers debit and automated teller machine (ATM), and credit cards; internet and mobile, and telephone banking services; and financial education services. The company operates 115 locations and 184 ATMs in metropolitan Chicago, southeast Wisconsin, northwest Indiana, central and western Illinois, eastern Iowa, and other markets in the Midwest. First Midwest Bancorp, Inc. was incorporated in 1982 and is headquartered in Chicago, Illinois.

Full FMBIO Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this FMBIO vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FMBIO vs SCHDFMBIO vs JEPIFMBIO vs OFMBIO vs KOFMBIO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.